Home » Neurowave, Alaven Sign Agreement for Device to Treat Pregnancy-Related Nausea
Neurowave, Alaven Sign Agreement for Device to Treat Pregnancy-Related Nausea
Neurowave Medical Technologies and Alaven Pharmaceutical
have entered into an exclusive licensing agreement under which Alaven will commercialize NMT’s
patented prescription neuromodulation pulse generator device for the treatment of pregnancy induced nausea and vomiting in the United States.
centredaily
centredaily
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May